Efficacy and safety of switching to iGlarLixi from premixed insulin therapy in patients with type 2 diabetes: A real-world experience
{{output}}
Aims: Fixed-ratio combinations such as iGlarLixi are recommended over premixed insulin as first-line injectable therapy for type 2 diabetes mellitus (T2DM), yet real-world evidence on transitions from premix to iGlarLixi remains ... ...
